Although, some cellular and tissue studies in PD patients argue against the excess of SNCA in pathogenesis of PD (Dächsel et al., 2007), recent studies reaffirm the increase in SNCA protein levels in iPSC-derived neurons from patient with PARK2 mutation (Imaizumi et al., 2012). The gene discussed is SNCA; the disease is Parkinson disease.